已确认可信度 84%The slip opinion in No. 23-235 is headed "Argued March 26, 2024—Decided June 13, 2024".[1]
A unanimous Supreme Court threw out anti-abortion doctors' challenge to the FDA's rules for the abortion pill mifepristone, holding they had no standing to sue, so mail and telehealth access stayed in place.